Search results
Results From The WOW.Com Content Network
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown ...
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NAS: EXAS) today announced that preliminary analysis shows that the company's Cologuard colorectal cancer screening test met or exceeded all ...
Google Docs is an online word processor and part of the free, web-based Google Docs Editors suite offered by Google, which also includes Google Sheets, Google Slides, Google Drawings, Google Forms, Google Sites and Google Keep. Google Docs is accessible via an internet browser as a web-based application and is also available as a mobile app on ...
Google Docs Editors is a web-based productivity office suite offered by Google within its Google Drive service. The suite includes Google Docs (word processor), Google Sheets (spreadsheet), Google Slides (presentation software), Google Drawings (vector drawing program), Google Forms (online forms, quizzes and surveys), Google Sites (graphical website editor), Google Keep (note-taking ...
What: Shares of EXACT Sciences , a molecular. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Exact Sciences (EXAS) reaches a co-promotion agreement with Pfizer to commercialize its non-invasive screening test for colorectal cancer, Cologuard. The stock rallies following this news.
Google Forms is a survey administration software included as part of the free, web-based Google Docs Editors suite offered by Google. The service also includes Google Docs, Google Sheets, Google Slides, Google Drawings, Google Sites, and Google Keep. Google Forms is only available as a web application. The app allows users to create and edit ...
Exact Sciences (EXAS) has pre-announced first quarter results, with total revenue up 114% year-over-year at $348 million, surpassing the Street estimate of $342.6 million.The company, which ...